U.S. Physical Therapy (USPH) Expected to Announce Quarterly Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) is expected to issue its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $0.55 per share and revenue of $200.9410 million for the quarter. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 10:30 AM ET.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.67 EPS for the quarter, hitting analysts’ consensus estimates of $0.67. U.S. Physical Therapy had a return on equity of 8.75% and a net margin of 5.07%.The company had revenue of $202.73 million during the quarter, compared to analysts’ expectations of $200.10 million. During the same quarter in the previous year, the firm posted $0.51 EPS. The firm’s revenue was up 12.3% compared to the same quarter last year. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $71.71 on Monday. The stock has a 50-day moving average of $77.16 and a two-hundred day moving average of $79.99. U.S. Physical Therapy has a one year low of $66.67 and a one year high of $93.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market cap of $1.08 billion, a P/E ratio of 50.50, a P/E/G ratio of 1.91 and a beta of 1.21.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 10th. Shareholders of record on Friday, March 13th were given a dividend of $0.46 per share. The ex-dividend date of this dividend was Friday, March 13th. This represents a $1.84 dividend on an annualized basis and a yield of 2.6%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.45. U.S. Physical Therapy’s payout ratio is presently 129.58%.

Insider Activity

In other news, EVP Richard Binstein sold 3,000 shares of the business’s stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $81.64, for a total value of $244,920.00. Following the completion of the transaction, the executive vice president owned 24,867 shares of the company’s stock, valued at $2,030,141.88. The trade was a 10.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Graham D. Reeve sold 662 shares of the business’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total value of $52,205.32. Following the completion of the transaction, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at approximately $2,371,951.08. This trade represents a 2.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently modified their holdings of USPH. Bank of America Corp DE increased its stake in shares of U.S. Physical Therapy by 77.2% in the 3rd quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock valued at $26,946,000 after purchasing an additional 138,194 shares in the last quarter. Schroder Investment Management Group increased its stake in shares of U.S. Physical Therapy by 45.9% in the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock valued at $29,603,000 after purchasing an additional 114,618 shares in the last quarter. 4D Advisors LLC purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at about $9,344,000. First Trust Advisors LP increased its stake in shares of U.S. Physical Therapy by 607.2% in the 4th quarter. First Trust Advisors LP now owns 69,834 shares of the company’s stock valued at $5,453,000 after purchasing an additional 59,959 shares in the last quarter. Finally, Two Sigma Investments LP increased its stake in shares of U.S. Physical Therapy by 718.8% in the 3rd quarter. Two Sigma Investments LP now owns 60,267 shares of the company’s stock valued at $5,120,000 after purchasing an additional 52,907 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on USPH shares. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Zacks Research cut U.S. Physical Therapy from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 28th. Barrington Research reissued an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a report on Friday, February 20th. Finally, Jefferies Financial Group raised U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $101.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.